Operating Income (Loss) in USD of RAPID MICRO BIOSYSTEMS, INC. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rapid Micro Biosystems, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2020 to Q3 2025.
  • Rapid Micro Biosystems, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$11.4M, a 5.54% increase year-over-year.
  • Rapid Micro Biosystems, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$45.4M, a 12.5% increase year-over-year.
  • Rapid Micro Biosystems, Inc. annual Operating Income (Loss) for 2024 was -$49.9M, a 11.7% increase from 2023.
  • Rapid Micro Biosystems, Inc. annual Operating Income (Loss) for 2023 was -$56.6M, a 10.5% increase from 2022.
  • Rapid Micro Biosystems, Inc. annual Operating Income (Loss) for 2022 was -$63.2M, a 33.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

RAPID MICRO BIOSYSTEMS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$45.4M -$11.4M +$667K +5.54% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 -$46.1M -$12.1M +$1.23M +9.19% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$47.3M -$11.7M +$2.61M +18.3% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q4 2024 -$49.9M -$10.2M +$1.96M +16.1% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 -$51.9M -$12M +$2.41M +16.7% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 -$54.3M -$13.4M +$1.68M +11.1% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$56M -$14.3M +$599K +4.03% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q4 2023 -$56.6M -$12.2M +$5.07M +29.4% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 -$61.6M -$14.4M +$2.44M +14.4% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$64.1M -$15.1M -$980K -6.96% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 -$63.1M -$14.9M +$127K +0.85% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024
Q4 2022 -$63.2M -$17.3M -$2.7M -18.6% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2024
Q3 2022 -$60.5M -$16.9M -$4.76M -39.3% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 -$55.8M -$14.1M -$3.21M -29.6% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 -$52.5M -$15M -$5.31M -54.8% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$47.2M -$14.6M 01 Oct 2021 31 Dec 2021 10-K 10 Mar 2023
Q3 2021 -$12.1M -$4.55M -60% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$10.9M -$4.85M -80.7% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$9.69M 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q3 2020 -$7.58M 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$6.01M 01 Apr 2020 30 Jun 2020 10-Q 27 Aug 2021

RAPID MICRO BIOSYSTEMS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$49.9M +$6.64M +11.7% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 -$56.6M +$6.66M +10.5% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 -$63.2M -$16M -33.8% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2024
2021 -$47.2M -$16.7M -54.7% 01 Jan 2021 31 Dec 2021 10-K 10 Mar 2023
2020 -$30.5M 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.